CLINICAL_TRIALS
trial_result
· 2024-02-14
Clinical Trial Update: Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD) [Phase 2]
Summary
Phase 2 trial update on a fatty acid amide hydrolase (FAAH) inhibitor for Cannabis Use Disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Cannabis Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14